Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysis

BACKGROUND: Interleukin-2 (IL-2) antagonist has been used as an induction therapy in many centres in calcineurin inhibitor-sparing regimens. Tacrolimus has overwhelmingly replaced cyclosporine in the maintenance immunosuppressive protocols in many transplant centres. The aim of our study and meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Hatem, Mohiuddin, Atif, Sharma, Ajay, Shaheen, Ihab, Kim, Jon Jin, El Kosi, Mohsen, Halawa, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Transplant Immune Suppression
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671558/
https://www.ncbi.nlm.nih.gov/pubmed/31384453
http://dx.doi.org/10.1093/ckj/sfy132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671558/
https://www.ncbi.nlm.nih.gov/pubmed/31384453
http://dx.doi.org/10.1093/ckj/sfy132

Ejemplares similares